Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRASPA in Elderly Ph- ALL
NCT01523782Phase 2Completed
- Sponsor
- PHAXIAM Therapeutics
- Start
- Apr 2009
- Primary completion
- Jan 2011
- Modality
- Replacement Enzymes
01
Overview
A Phase 2 trial of eryaspase in acute lymphoblastic leukemia (ALL), sponsored by PHAXIAM Therapeutics. Started Apr 2009; status: completed.
02
Drugs
eryaspase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01523782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523782.